Drug comparisons
Lasmiditan vs Ubrogepant
Lasmiditan (Reyvow) vs Ubrogepant (Ubrelvy) for migraine treatment: Lasmiditan acts on 5-HT1F receptors while Ubrogepant blocks CGRP. Both are oral options without vasoconstriction risks associated with older triptans.
No comparison dimensions are available for this page.
Clinical context
Patients experiencing acute migraine who cannot tolerate traditional triptans or have heart-related concerns often compare Lasmiditan and Ubrogepant.
Bottom line
Both Lasmiditan and Ubrogepant offer effective options for acute migraine relief but the optimal choice varies by patient-specific factors.
All medication comparisons